Jinling Pharmaceutical Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	13.4yrs
Gemiddelde ambtstermijn bestuur	1.4yrs

Recente managementupdates

Recent updates

CEO

Jinling Pharmaceutical heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yang Wang	VP, Chief Accountant & Non-Independent Director	no data	CN¥755.40k	0.039% CN¥ 1.7m
Sheng Chen	VP & Non-Independent Director	no data	CN¥959.90k	0.050% CN¥ 2.1m
Quan Li	Chief Economist	no data	CN¥699.70k	0.029% CN¥ 1.2m
Mingyi Jia	Chief Engineer	no data	CN¥747.50k	0.029% CN¥ 1.2m
Jian Wang	VP & Non-Independent Director	5.6yrs	CN¥761.40k	0.027% CN¥ 1.2m
Jun Yang Xu	Secretary	26.2yrs	CN¥433.40k	0.027% CN¥ 1.1m
Xinning Zhu	Assistant to President	no data	CN¥630.60k	0.026% CN¥ 1.1m
Zhenxin Xi	General Manager Assistant	no data	CN¥522.50k	0.016% CN¥ 687.9k
Wei Guo Tang	Executive Vice President	13.4yrs	CN¥141.40k	geen gegevens

13.4yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 000919 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 13.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yang Wang	VP, Chief Accountant & Non-Independent Director	1.4yrs	CN¥755.40k	0.039% CN¥ 1.7m
Sheng Chen	VP & Non-Independent Director	4.4yrs	CN¥959.90k	0.050% CN¥ 2.1m
Jian Wang	VP & Non-Independent Director	1.4yrs	CN¥761.40k	0.027% CN¥ 1.2m
Yusheng Zhou	Non-Employee Supervisor	1.4yrs	geen gegevens	geen gegevens
Hongqin Li	Chairman of the Supervisory Board	7.4yrs	geen gegevens	geen gegevens
Yongjian Shen	Independent Director	4.4yrs	CN¥100.00k	geen gegevens
Yanping Gao	Independent Director	4.4yrs	CN¥100.00k	geen gegevens
Guangyu Yan	Non-Employee Supervisor	4.4yrs	geen gegevens	geen gegevens
Xiaoqiang Cao	Non-independent Director	1.4yrs	geen gegevens	geen gegevens
Qunhong Zhang	Non-Independent Director	1.4yrs	geen gegevens	geen gegevens
Junping Kou	Independent Director	1.4yrs	CN¥50.00k	geen gegevens
Lei Niu	Employee Supervisor	1.4yrs	geen gegevens	0.011% CN¥ 481.5k

1.4yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 000919 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.4 jaar), wat duidt op een nieuw bestuur.

Jinling Pharmaceutical Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Jinling Pharmaceutical Company Limited, Annual General Meeting, May 21, 2024

High number of new directors

Jinling Pharmaceutical Company Limited Approves Management Appointments

Jinling Pharmaceutical Company Limited, Annual General Meeting, May 23, 2023

High number of new and inexperienced directors

High number of new directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.031 (vs CN¥0.04 in 3Q 2023)

Investor sentiment improves as stock rises 19%

Jinling Pharmaceutical Company Limited to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0.013 (vs CN¥0.067 in 2Q 2023)

Jinling Pharmaceutical Company Limited to Report First Half, 2024 Results on Aug 27, 2024

Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024

Jinling Pharmaceutical Company Limited, Annual General Meeting, May 21, 2024

First quarter 2024 earnings released: EPS: CN¥0.085 (vs CN¥0.087 in 1Q 2023)

New minor risk - Shareholder dilution

Jinling Pharmaceutical Company Limited to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment deteriorates as stock falls 15%

Jinling Pharmaceutical Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.066 in 3Q 2022)

Jinling Pharmaceutical Company Limited to Report Q3, 2023 Results on Oct 31, 2023

Second quarter 2023 earnings released: EPS: CN¥0.067 (vs CN¥0.039 in 2Q 2022)

High number of new directors

Jinling Pharmaceutical Company Limited Approves Management Appointments

Jinling Pharmaceutical Company Limited, Annual General Meeting, May 23, 2023

Full year 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.24 in FY 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.066 (vs CN¥0.043 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.039 (vs CN¥0.081 in 2Q 2021)

Jinling Pharmaceutical Company Limited Implements Final Profit Distribution for 2021, Payable on August 11, 2022

High number of new directors

Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2021

Jinling Pharmaceutical Company Limited, Annual General Meeting, Jun 28, 2022

First quarter 2022 earnings released: EPS: CN¥0.077 (vs CN¥0.069 in 1Q 2021)

Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2021

Full year 2021 earnings released: EPS: CN¥0.24 (vs CN¥0.13 in FY 2020)

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.043 (vs CN¥0.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.10 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.069 (vs CN¥0.055 loss in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.13 (vs CN¥0.29 in FY 2019)

Jinling Pharmaceutical Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: CN¥6.50

New 90-day high: CN¥8.02

New 90-day high: CN¥7.50

Third quarter earnings released

New 90-day low: CN¥6.61

Earnings released

Jinling Pharmaceutical Company Limited to Report First Half, 2020 Results on Aug 25, 2020

New 90-day high - CN¥7.34

CEO

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd